Dopamine D2 receptors in the accumbal core region mediates the effects of fentanyl on sleep-wakefulness

Rishi Sharma,Meet Parikh,Abigail Chischolm,Deepak Kempuraj,Mahesh Thakkar

DOI: https://doi.org/10.2139/ssrn.4816954

2024-09-14

Neurosciences

Abstract:Highlights • Fentanyl was administered at dark onset and sleep-wakefulness (S-W) was examined. • Fentanyl administration significantly increased wakefulness for the first 6h. • This initial increase in wakefulness was followed by a rebound sleep for next 6h. • Sulpiride was injected in the accumbal core before fentanyl and S-W was examined. • D2R blockade by sulpiride in the core attenuated the effects of fentanyl on S-W. Fentanyl, a potent analgesic and addictive substance, significantly impacts sleep-wakefulness (S-W). Acutely, it promotes wake, whereas chronic abuse leads to severe sleep disruptions, including insomnia, which contributes to opioid use disorders (OUD), a chronic brain disease characterized by compulsive opioid use and harmful consequences. Although the critical association between sleep disruptions and fentanyl addiction is acknowledged, the precise mechanisms through which fentanyl influences sleep remain elusive. Recent studies highlight the role of the dopaminergic system of the nucleus accumbens (NAc) in S-W regulation, but its specific involvement in mediating fentanyl's effects on S-W remains unexplored. We hypothesized that dopamine D2 receptors mediate fentanyl-induced effects on S-W. To test this hypothesis, male C57BL/6J mice, instrumented with sleep recording electrodes and bilateral guide cannulas above the accumbal core region (NAcC), were utilized in this study. At dark onset, animals were bilaterally administered sulpiride (D2 receptors antagonist; 250 ng/side) in the NAcC followed by an intraperitoneal injection of fentanyl (1.2 mg/Kg). S-W was examined for the next 12h. We found that systemic administration of fentanyl significantly increased wakefulness during the first 6h of the dark which was followed by a significant increase in NREM and REM sleep during the second 6h of the dark period. D2-receptor blockade significantly reduced this effect as evidenced by a significant reduction in fentanyl-induced wakefulness during first 6h of dark period and sleep rebound during the second 6h. Our findings suggest that D2 receptors in the NAcC plays a vital role in mediating the fentanyl-induced changes in S-W. Graphical abstract Download: Download high-res image (42KB) Download: Download full-size image

clinical neurology